Questions and expectations swirl as Monarez steps into director's role at CDC
The CDC has lost nearly a quarter of its staff since January, thanks to massive workforce cuts at federal health agencies. The Trump administration's proposed budget for the fiscal year 2026 would slash the agency's funding by more than half. And under a proposed reorganization, the agency stands to lose more of its programs: Some are set to be moved to a new Administration for a Healthy America while others, such as the National Center for Chronic Disease and Health Promotion, would be eliminated altogether.
All this is playing out as US Health and Human Services Secretary Robert F. Kennedy Jr., who has long promoted misinformation about vaccines, has moved to undermine longstanding federal policies and processes that support vaccination in the United States.
Kennedy has also throttled communications coming out of federal health agencies, including the CDC, all but silencing its scientists amid the worst measles outbreak in the US in three decades.
Many at the agency and in the wider public health world are wondering whether Monarez will prove to be a savior or a sycophant.
Morale among agency staff is bleak, according to one CDC official who spoke on the condition that they not be named for fear of reprisals.
Staffers are feeling unsure about what Monarez's confirmation means, the official said. Many see her as a good scientist and someone with experience in leadership positions at federal agencies.
But they also wonder whether she'll be constrained by Kennedy, the official said.
Monarez's tenure in government spans Republican and Democratic administrations. Before coming to the CDC in January, she was deputy director for the Advance Research Projects Agency for Health, or ARPA-H, and was founding director of the Center for Innovation at the Health Resources and Services Administration. She held other leadership positions at the Department of Homeland Security and the Biomedical Advanced Research and Development Authority.
In her confirmation hearing, Monarez described herself as the daughter of a dairy farmer from rural Wisconsin who attended state schools and paid her own way through college, eventually earning a Ph.D. in microbiology and immunology. She said that her research was focused on two diseases, African sleeping sickness and toxoplasmosis, and that she was drawn to public health because treatments for those diseases remain limited but public health interventions have reduced the impact of the diseases.
Under questioning by senators, Monarez seemed to distance herself from Kennedy on two issues: vaccines and fluoride.
In response to questions from Sen. Bernie Sanders, an independent from Vermont, about the US ending its support for the Global Alliance for Vaccines and Immunization, Monarez said, 'I think vaccines save lives. I think that we need to continue to support the promotion and utilization of vaccines.'
When Sanders asked whether she agrees that there is no scientific proven link between vaccines and autism, Monarez said, 'I have not seen a causal link between vaccines and autism.'
Regarding fluoride, Monarez told Sen. Angela Alsobrooks that she considered it 'an important component to oral health. … The direct application can be very valuable.'
Alsobrooks asked about fluoridation of public drinking water, including in Monarez's own town. 'They have fluoridation there. Is it safe for families, the water in Potomac, Maryland?'
'I believe the water in Potomac, Maryland, is safe,' Monarez answered.
One staffer who worked under Monarez at ARPA-H described her as a quiet presence. She wasn't the type of manager who is an active presence on Slack or email, they said.
'We all respected her. She's been in government a long time,' said the staffer, who spoke on the condition that they not be named for fear of retaliation.
Dr. Jennifer Nuzzo, who directs the Pandemic Center at Brown University's School of Public Health, has known Monarez for at least a decade.
'She's a lifelong government scientist who has risen through the ranks to become a very senior leader,' Nuzzo said. 'She's loyal to serving the American people.'
They worked together when Monarez was detailed to the White House, where she worked on the US National Action Plan for Combating Antibiotic-Resistant Bacteria.
'She got into the nitty-gritty of a complex policy issue, but she was also able to bring together a really diverse set of stakeholders to provide input into that strategy,' Nuzzo said. 'I think that's a great example of what Susan does.'
Monarez has said she has three priorities for the CDC.
First, she said, she wants to improve trust in the agency and its recommendations. Next, she will focus on strengthening public health infrastructure by investing in tools to prevent, detect and respond to threats in near real-time. She pledged to collaborate with state and local public health departments to build a nationwide public health network. Finally, she said, she will work to create rapid, evidence-based responses to public health emergencies, with timely communication that is consistent and grounded in facts.
While these are worthy goals, Nuzzo said, her biggest worry is whether Monarez will be able to act independently, without political interference.
'You can't run an organization as important and large as the CDC if you need to get permission for everything that needs to be done,' Nuzzo added.
Dr. Richard Besser, a former acting director of the CDC, said in a statement that he looked forward to meeting Monarez to better understand her plans to lead the agency. Besser is now president and CEO of the Robert Wood Johnson Foundation.
'Dr. Monarez must not only lead the CDC – she must fight for it. Our nation's entire public health system depends on CDC having the tools it needs to respond to pandemics, reduce chronic disease, and address health inequities that continue to leave too many communities behind. That starts with a director willing to speak the truth, defend science, and stand up for the health of every American,' Besser said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
37 minutes ago
- Yahoo
Teenager and Toddler Contract Parasite Spread by Exposure to Raccoon Feces
The two unrelated children were hospitalized and treated for B. procyonis infectionsNEED TO KNOW Two California children contracted a rare parasite commonly spread by raccoon feces and occasionally by dogs The two unrelated kids — a teenager and a toddler — were hospitalized and treated for B. procyonis infections in 2024 The Centers for Disease Control and Prevention (CDC) says people should "avoid contact with raccoons and their feces"Two children in California contracted a rare parasite that is commonly spread by raccoon feces and occasionally by dogs. The Centers for Disease Control and Prevention (CDC) detailed two 2024 cases of a B. procyonis infection found in two unrelated children — a 14-year-old boy and a 15-month-old boy — in its latest Morbidity and Mortality Weekly Report, published on Thursday, July 31. The infection, commonly referred to as raccoon roundworm infection, is caused by the Baylisascaris procyonis roundworm, which is often spread by exposure to raccoon feces and can also be transmitted to dogs in rare cases. According to the report, the Los Angeles County Department of Public Health (LACDPH) was notified last year of two patients with neurological signs and symptoms — such as behavioral change, lethargy and "gait instability" — consistent with the infection. Both cases were in the South Bay area of Los Angeles County, according to a LACDPH release from September 2024. According to the CDC, raccoons can "shed millions of roundworm eggs in their feces every day," which then become infective after a few weeks and can develop into larvae when consumed by "nondefinitive hosts." There have only been 35 cases in humans reported in the U.S., the health organization said. The teenage boy, who is autistic, had a history of ingesting non-food items and was initially hospitalized in May 2024 due to a series of "behavioral changes," according to the new information from the CDC. After "enhancing" lesions were detected in the boy's brain, doctors discovered and treated what the CDC called "a live parasitic nematode" in his eye. The teen was prescribed medication for a six-week period, before symptoms "subsequently resolved" and he returned to his "baseline neurologic status," according to the agency. The second patient, a toddler, was also hospitalized that June, before a brain MRI found "diffuse white matter abnormalities." Months later, doctors eventually discovered a "live parasitic nematode" in his eye — which, like the older boy, was treated with a laser. Both boys were also treated with a drug for paramedic worms, albendazole and the anti-inflammatory corticosteroids. While a source of the infection was not clear for the toddler, the CDC reported that a raccoon latrine — or an area where the animals defecate — was located on the rooftop of the teenager's home, "directly above the entrance to the premises, allowing feces to roll onto the landing below." The child was suspected to have consumed the feces or feces-contaminated soil. Due to the extent that raccoons visit the home, and unsuccessful efforts to move the animal's latrine, the family is planning on moving, the CDC said. "Given the severity of disease in humans, the high prevalence of B. procyonis infection in raccoons, and the proximity of raccoons to humans and pets, B. procyonis is a substantial public health concern," the CDC said. "To prevent infection, the public should avoid contact with raccoons and their feces, not keep raccoons as pets, ensure that children or persons with developmental disabilities do not place contaminated objects or fingers into their mouths, practice good hand hygiene after outdoor activities and safely remove raccoon latrines on properties, paying special attention to flat surfaces such as rooftops, decks, tree stumps, or unsealed attics and other areas where raccoons prefer to defecate," they continued. Since dogs can also be infected, the CDC encourages dog owners to prevent their pets from eating raccoon feces and said pets should be treated with a "year-round parasite prevention product." Read the original article on People
The Hill
5 hours ago
- The Hill
Kennedy targets vaccination injury program
Health secretary Robert F. Kennedy Jr. is targeting a little-known but crucial program that underpins all childhood vaccinations. Kennedy took to social media and the show of conservative activist Charlie Kirk this week to rail against the Vaccine Injury Compensation Program and pledge significant changes. 'The VICP is broken, and I intend to fix it,' he wrote on social platform X. 'I will not allow the VICP to continue to ignore its mandate and fail its mission of quickly and fairly compensating vaccine-injured individuals.' Attorneys and other experts say Kennedy is right that the program, which was created in 1986 in order to give quick payouts to families who can prove a child was injured from a vaccine, is badly in need of modernization. 'There's a lot of low hanging fruit that [Kennedy] can act on that would immediately alter the course of the vaccine program for the better,' said David Carney, a vaccine injury attorney in Philadelphia and president of the Vaccine Injured Petitioners Bar Association. Cases could be settled quicker, rather than going through a trial, Carney said. Kennedy could also press Congress to act on legislation that would increase the court staff, increase the pain and suffering caps, and add COVID-19 vaccines to the list of shots eligible for the program. It has too few staff available to handle a massive caseload, leaving patients waiting for years just to have their cases heard. It covers almost three times as many vaccines as when it was first created, but the number of 'special masters' who hear cases has stayed the same. Attorneys who argue vaccine injuries said the government has been more favorable to vaccines than petitioners in recent years, fighting against claims that would have previously been easily settled. 'It's not the fast, informal, petitioner-friendly program that Congress designed. It is very adversarial and litigious. That's absolutely, 100% true,' said Renée Gentry, director of the Vaccine Injury Litigation Clinic at George Washington University Law School. But there's fear the changes Kennedy wants will undermine the program, or tear it down entirely, risking driving drugmakers from the market and threatening access to childhood shots. Kennedy has long targeted the VICP, and his X post echoed many of his previous arguments. He did not elaborate on what changes he is making but said he is working with Attorney General Pam Bondi. He has previously said he wants to expand the program, making it easier for claimants to qualify for awards based on adverse events he claims are associated with vaccines but are not currently part of the program. People can prove injuries two ways, said Dorit Reiss, a vaccine law expert and law professor at UC San Francisco. Either you fit into the table of injuries, and then there's a presumption that the vaccine caused the harm, or you have to show causation for an injury outside the list. Kennedy has the power to add new injuries to the eligible list, like autism, which he has repeatedly linked to vaccines. In an interview with Tucker Carlson earlier in July, Kennedy also suggested vaccines are linked to numerous chronic ailments like diabetes and narcolepsy. 'We have now this epidemic of immune dysregulation in our country, and there's no way to rule out vaccines as one of the key culprits,' Kennedy said. In order to add an injury to the list, Kennedy would have to go through the federal government's cumbersome notice-and-comment rulemaking process. Experts said it's usually a time consuming and expensive undertaking, and often the scientific reviews don't show enough evidence to prove if the vaccine caused harm or not. Kennedy could also unofficially start settling cases for more injuries without adding them to the list. Yet either change could risk bankrupting the program. Families are paid through a trust fund that's funded by an excise tax on vaccine makers, so there's a finite pot of money available. The program's fund covers lawyers' fees and the costs, even for losing cases. In exchange for the tax, vaccine makers have a limited liability shield. Petitioners file claims against the federal government, not the manufacturers, and families can get compensation without having to prove that drugmakers were negligent. Kennedy has suggested he wants to change that. 'The VICP has devolved into a morass of inefficiency, favoritism, and outright corruption as government lawyers and the Special Masters who serve as Vaccine Court judges prioritize the solvency of the HHS Trust Fund, over their duty to compensate victims,' Kennedy wrote. An HHS spokesman declined to say what, if any changes Kennedy is considering, saying the secretary's comments speak for itself. A popular anti-vaccine talking point is the desire to eliminate the vaccine makers' limited liability shield. But that's only something Congress can do. Kennedy does have the power to drop vaccines from the program. Right now, it covers 16 routinely recommended immunizations for children or pregnant women. But if a shot is no longer routinely recommended, it can be removed. In early June, Kennedy abruptly fired all members of the outside advisory group responsible for making vaccine recommendations. He appointed a new group of hand-picked replacements. If that group no longer recommends the HPV vaccine, for instance, Kennedy can revise the injury table to remove it. 'If he takes it away, then those people have no right to be in this program, and they're going to have to be stuck with civil litigation,' said Gentry, which is much more difficult and expensive.
Yahoo
5 hours ago
- Yahoo
Menopause increases your risk of STIs due to how aging changes your body
Diagnoses for sexually transmitted infections, or STIs, are increasing in older adults. The Centers for Disease Control and Prevention reports the number of people older than 65 diagnosed with chlamydia, gonorrhea or syphilis in the U.S. increased about three-, five- and sevenfold, respectively, from 2010 to 2023. Data also suggests that women older than 50 are at greater risk for HIV than younger women. Explanations for why these infections are so common in older adults include limited understanding of STIs in this age group, infrequent condom use and increased availability of medications for conditions that typically limit sexual activity in older adults, such as like Viagra and Cialis for erectile dysfunction and estrogen creams and tablets for vaginal dryness. Many older adults are reluctant to discuss their sexual history with their partners and health care providers, which contributes to misconceptions that they are monogamous or sexually inactive. In my work as an infectious disease scientist, I examine the largely unexplored biological reasons for why postmenopausal women have increased susceptibility to STIs. My recently published research shows that menopause is associated with loss of the genital tract's protective barrier, an essential defense against the microbial pathogens that cause STIs. Menopause: A natural part of aging Menopause is the stage in a woman's life marked by no menstrual periods for 12 consecutive months. In the U.S., menopause begins on average between ages 45 and 55. It is estimated that by the year 2030, 1.2 billion women worldwide will be menopausal or postmenopausal. Menopause results from a loss of estrogen production from the ovaries, which can diminish vaginal lubrication and vaginal tissue elasticity. This can cause a condition called genitourinary syndrome of menopause, or GSM, which involves symptoms such as vaginal dryness and irritation, painful sex and frequent urinary tract infections. Roughly half of postmenopausal women experience GSM. In addition to these negative effects on vaginal health, research from my lab has found that menopause also compromises the structural integrity of the tissue lining the vagina. The surface of the vagina is composed of multiple layers of epithelial cells that are held together by numerous adhesion molecules, including the proteins desmoglein-1, or DSG1, and desmocollin-1, or DSC1. These proteins strengthen the vaginal lining and restrict pathogen access to deeper tissue, reducing the risk of infection. To explore how menopause affects the vaginal lining, we compared the DSG1 and DSC1 levels in vaginal tissue from postmenopausal and premenopausal women. We found significantly lower DSG1 and DSC1 levels in postmenopausal women. We then surgically removed the ovaries of mice to model the loss of ovarian estrogen production in postmenopausal women. We also detected significantly less DSG1 and DSC1 proteins in vaginal tissue from mice without ovaries compared with mice with intact ovaries. Mice without ovaries also had greater susceptibility to infection with herpes simplex virus type 2, or HSV-2, and were less able to clear chlamydia infection from their lower genital tract. On the other hand, applying estrogen cream to mice without ovaries restored the integrity of their vaginal lining and fully protected these mice from HSV-2 infection. Too important to ignore Fully understanding the behavioral and biological risk factors that contribute to STI susceptibility can help clinicians and public health officials tackle the startling increases in STIs among older adults. Together, our studies show there is a loss of integrity in the vaginal lining after menopause. While additional research is needed, findings from our lab suggest that estrogen-containing compounds used to relieve vaginal irritation and other symptoms of genitourinary syndrome of menopause can also reduce susceptibility to STIs among older adults. In the meantime, health care providers can help reduce the risk of STIs among older adults by consistently counseling them about safe sex practices and offering routine STI screening. This article is republished from The Conversation, a nonprofit, independent news organization bringing you facts and trustworthy analysis to help you make sense of our complex world. It was written by: Thomas L. Cherpes, The Ohio State University Read more: Millions of women are working during menopause, but US law isn't clear on employees' rights or employers' obligations Iceland's recent volcanic eruptions driven by pooling magma are set to last centuries into the future The sex of your cells matters when it comes to heart disease Thomas L Cherpes receives funding from the National Institute on Aging and the National Institute of Child Health and Human Development
